Trandolapril - HY-B0592
Nur noch %1 verfügbar
Catalog #
HY-B0592
Ab
53,00 €
Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0592/Trandolapril-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-anti-virus |
| Alternative Names | RU44570 |
| CAS | 87679-37-6 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 430.54 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Angiotensin-converting Enzyme (ACE) |
| Application: | COVID-19-anti-virus |
|---|